OCATA THERAPEUTICS
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of OCATA THERAPEUTICS generated cash of -$21,447,451, which is more than the previous year. Cash used in financing activities reached the amount of $24,391,715 last year. Net change in cash is therefore $2,680,889.
Cash Flow
| 2013 | -21.96M | -710.77K | 17.17M |
|---|---|---|---|
| 2014 | -21.44M | -263.37K | 24.39M |
OCAT Cash Flow Statement (2013 – 2014)
| 2014 | 2013 | |
|---|---|---|
Cash at beginning of period | 1.74M | 7.24M |
Operating activities | ||
Net income | -34.74M | -31.02M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||
Depreciation and amortization | 564.28K | 1.21M |
Stock-based compensation expense | 0 | 3.88M |
| Deferred income tax benefit | 0 | 3.88M |
| Changes in operating assets and liabilities: | ||
Accounts receivable, net | 1.34B | 0 |
Inventories | -1.32B | 0 |
Accounts payable | -3.21M | -2.05M |
Cash generated by operating activities | -21.44M | -21.96M |
Investing activities | ||
Purchases Of Investments | 0 | 0 |
Investments In Property Plant And Equipment | -263.37K | -671.82K |
Acquisitions Net | 0 | 0 |
Cash generated by investing activities | -263.37K | -710.77K |
Financing activities | ||
Common Stock Issued | 25.66M | 17.77M |
Payments for dividends | 0 | -34.06M |
Repurchases of common stock | -4.42M | -1.74M |
Repayments of term debt | -1.2M | -600K |
Cash used in financing activities | 24.39M | 17.17M |
Net Change In Cash | 2.68M | -5.49M |
Cash at end of period | 4.42M | 1.74M |
| Data source | Data source |